IL6 and lung carcinoma: In selected lung cancer cell lines, persistently activated or tyrosine-phosphorylated STAT3 is partially due to IL-6 induction, and IL-6/p-STAT3 pathway activation is confirmed to be critical for lung cancer progression [41].